glp-1/gip agonist GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP-1 Receptor Agonists Explained for
Description
This allows for proper risk assessment and an appropriate care plan before starting therapy
Cell Signal
10.1126/scitranslmed.abe5795 52 MehdiS
GLP-1 receptor agonist as treatment for cancer as well as diabetes: Beyond blood glucose control
Tailoring treatment helps people lose fat while protecting muscle and function
